Artificial Intelligence in Drug Design—The Storm Before the Calm?
- 2 November 2018
- journal article
- editorial
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 9 (12) , 1150-1152
Abstract
Artificial intelligence in drug design in experiencing a wave of excitement not seen since the emergence of computational chemistry in the late 1980s and early 1990s. Apparently failing to learn the lessons of recent history, we are promised imminent and pervasive solutions to the ills of drug design and significant increases in productivity as we seek to deliver innovative new therapeutics. However, do significant issues remain to be answered before AI enters the day-to-day toolbox of the practicing medicinal chemist?Keywords
Funding Information
- Cancer Research UK (C5759/A17098, C480/A11411)
This publication has 4 references indexed in Scilit:
- Efficient Syntheses of Diverse, Medicinally Relevant Targets Planned by Computer and Executed in the LaboratoryChem, 2018
- Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?Journal of Medicinal Chemistry, 2015
- What Do Medicinal Chemists Actually Make? A 50-Year RetrospectiveJournal of Medicinal Chemistry, 2011
- The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug CandidatesJournal of Medicinal Chemistry, 2011